Editor's Note :

close editor's note Editor's Note :

Our coverage of Judge Brett Kavanaugh’s nomination to the Supreme Court is available at this link.

Regeneron Pharmaceuticals Inc. v. Merus N.V.

Pending petition
Docket No. Op. Below Argument Opinion Vote Author Term
17-1616 Fed. Cir TBD TBD TBD TBD TBD

Issue: Whether a patent right can be fully extinguished based on misconduct committed by the patentee’s counsel during federal district court litigation to enforce the patent right.

SCOTUSblog Coverage

DateProceedings and Orders
Mar 07 2018Application (17A945) to extend the time to file a petition for a writ of certiorari from March 26, 2018 to May 25, 2018, submitted to The Chief Justice.
Mar 08 2018Application (17A945) granted by The Chief Justice extending the time to file until May 25, 2018.
May 25 2018Petition for a writ of certiorari filed. (Response due July 2, 2018)
Jun 01 2018Waiver of right of respondent Merus N.V. to respond filed.
Jun 05 2018DISTRIBUTED for Conference of 6/21/2018.
Jun 08 2018Response Requested. (Due July 9, 2018)
Jun 19 2018Motion to extend the time to file a response from July 9, 2018 to August 8, 2018, submitted to The Clerk.
Jun 20 2018Motion to extend the time to file a response is granted and the time is extended to and including August 8, 2018.
Jun 29 2018Brief amicus curiae of New York Intellectual Property Law Association in support of neither Party Filed.
Jul 09 2018Brief amicus curiae of Intellectual Property Law Association of Chicago filed.
Jul 09 2018Brief amicus curiae of National Association of Patent Practitioners in support of neither party filed.
Jul 09 2018Motion for leave to file amici brief filed by Seven Chicago Patent Lawyers.
Jul 09 2018Brief amicus curiae of Washington Legal Foundation filed.
Aug 08 2018Brief of respondent Merus N.V. in opposition filed.
Aug 21 2018Reply of petitioner Regeneron Pharmaceuticals, Inc. filed.
Aug 22 2018DISTRIBUTED for Conference of 9/24/2018.
Term Snapshot